Your browser doesn't support javascript.
loading
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma.
Schulte, Lena; Scheiner, Bernhard; Voigtländer, Torsten; Koch, Sandra; Schweitzer, Nora; Marhenke, Silke; Ivanyi, Philipp; Manns, Michael P; Rodt, Thomas; Hinrichs, Jan B; Weinmann, Arndt; Pinter, Matthias; Vogel, Arndt; Kirstein, Martha M.
Afiliação
  • Schulte L; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Scheiner B; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Voigtländer T; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Koch S; Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Schweitzer N; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Marhenke S; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Ivanyi P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany.
  • Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Rodt T; Hannover Medical School, Institute for Diagnostic and Interventional Radiology, Hannover, Germany.
  • Hinrichs JB; Hannover Medical School, Institute for Diagnostic and Interventional Radiology, Hannover, Germany.
  • Weinmann A; Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Pinter M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Kirstein MM; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Liver Int ; 39(4): 714-726, 2019 04.
Article em En | MEDLINE | ID: mdl-30663219
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Neoplasias Hepáticas / Metformina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Neoplasias Hepáticas / Metformina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article